Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign “It doesn’t take an expert to say why a company that has earned US$45 billion from pneumonia vaccine sales…doesn’t need a subsidy to sell at lower prices” - the AC’s Ananth Ganesan @ganesan_ananth on Gavi’s failure to support more affordable vaccines. 13:30 - 27 Aug 2019